Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-001017

Options or other derivatives

  • GENERAL COUNSEL/CORPORATE SECR acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Belloff Neil S. · GENERAL COUNSEL/CORPORATE SECR

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-09-12 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +100,000 100,000 D
Loading xslF345X03/form4-09132019_040906.xml…